HCFA Relaxes Grip On MCAC, Allowing Informal Comment On Coverage
This article was originally published in The Gray Sheet
The Health Care Financing Administration is giving its Medicare Coverage Advisory Committee a wider berth in discussing whether or not a device warrants Medicare coverage during reviews by the various panels.
You may also be interested in...
HCFA's Medicare Coverage Advisory Committee reached a favorable decision for ambulatory blood pressure monitors (ABPMs) after adopting what it termed a "practical" approach for a technology that is difficult to study in a randomized setting.
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.
The termination of the Aurobindo-Sandoz deal isn’t perhaps all bad news for the Indian firm and the flip side may be an improved balance sheet, according to some analysts. But the resolution of compliance issues at manufacturing facilities remains critical.